In today’s recent session, 0.63 million shares of the Lifecore Biomedical Inc (NASDAQ:LFCR) have been traded, and its beta is 0.97. Most recently the company’s share price was $3.92, and it changed around -$2.42 or -38.17% from the last close, which brings the market valuation of the company to $121.01M. LFCR at last check was trading at a discount to its 52-week high of $9.09, offering almost -131.89% off that amount. The share price’s 52-week low was $4.47, which indicates that the recent value has fallen by an impressive -14.03% since then. We note from Lifecore Biomedical Inc’s average daily trading volume that its 10-day average is 0.11 million shares, with the 3-month average coming to 213.56K.
Lifecore Biomedical Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended LFCR as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Lifecore Biomedical Inc is expected to report earnings per share of -0.12 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Lifecore Biomedical Inc (NASDAQ:LFCR) trade information
Instantly LFCR has been showing red trend so far today with a performance of -38.17% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 6.38 on recent trading dayincreased the stock’s daily price by 38.56%. The company’s shares are currently down -36.67% year-to-date, but still down -31.11% over the last five days. On the other hand, Lifecore Biomedical Inc (NASDAQ:LFCR) is -38.56% down in the 30-day period. We can see from the shorts that 2.82 million shares have been sold at a short interest cover period of 18.52 day(s).
Lifecore Biomedical Inc (LFCR) estimates and forecasts
Lifecore Biomedical Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -52.54 percent over the past six months and at a 28.33% annual growth rate that is well above the industry average of 18.20%. The year-over-year growth rate is expected to be 7.60%, up from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 137.98M in revenue for the current quarter. 1 analysts expect Lifecore Biomedical Inc to make 27.72M in revenue for the current ending quarter. Analysts predict that the company’s current quarter sales will jump, forecast at 7.60%.
Lifecore Biomedical Inc earnings are expected to increase by -287.50% in 2024, but the outlook is positive 10.00% per year for the next five years.
LFCR Dividends
Lifecore Biomedical Inc’s next quarterly earnings report is expected to be released in September.
Lifecore Biomedical Inc (NASDAQ:LFCR)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 5.83% of Lifecore Biomedical Inc shares, and 67.80% of them are in the hands of institutional investors. The stock currently has a share float of 72.00%.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Mar 31, 2024. The former held 775.94 shares worth $3.32 million, making up 2.51% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 455.66 shares worth around $1.95 million, which represents about 1.48% of the total shares outstanding.
